Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Bayer/PPD Implitapide Development Follows Zetia Model As Statin Add-On

Feb 16 2004

• By The Pink Sheet

Related Content

Schering Sales Force Recruitment Is 80% Complete; Morale Remains High

Feb 02 2004

Baycol Withdrawal Gives Boost To Pravachol; Will Crestor NDA Be Affected?

Aug 13 2001

Zetia/Zocor Market Will Be First-Line Patients, Not Switches, Merck Says

Dec 22 2003

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window